Patients can be persuaded to place almost as much confidence in diagnostic AI as they have in primary care physicians.

Washington has been all over AI this week. One highlight: OpenAI CEO Sam Altman testifying strongly in favor of federal AI oversight.

America’s two major political parties agree on very little of late, but they have a mutual interest in working together toward overseeing AI.

The National Science Foundation (NSF) is setting up seven new institutes for studying foundational AI. Two of the initiatives have healthcare as a prime focus.

Unexpected empathy: Blinded healthcare professionals consistently scored the AI—yes, a ChatGPT model—higher than the doctors even for bedside manners.

Every industry on earth is buzzing over the promise and potential of ChatGPT and similarly sharp AI models, whether “large language” or another generative form. Healthcare is no exception. But shouldn’t it be?

Welcome to Movers & Shakers, a roundup of the latest executive movements in the healthcare industry.

Fresh off its success using AI to develop a blockbuster COVID vaccine, up-and-coming biotech player Moderna (founded 2010) has won the confidence of 112-year-old Big Blue as a strategic partner.